MONTREAL, March 26, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, GBA-driven Parkinson's disease and AAT-deficient lung and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Congruence Therapeutics Announces Participation in the 24th Annual Needham Virtual Healthcare Conference )
Also on site :